MedPath

广东怡至药品研究院有限公司

Ownership
-
Established
2018-06-19
Employees
-
Market Cap
-
Website

Clinical Trials

0

Active:0
Completed:0

Trial Phases

0 Phases

Drug Approvals

1

NMPA:1

Drug Approvals

Desloratadine Tablets

Product Name
地氯雷他定片
Approval Number
国药准字H20243706
Approval Date
May 15, 2024
NMPA

Clinical Trials

No trials found

News

No news found

MedPath

Empowering clinical research with data-driven insights and AI-powered tools.

© 2025 MedPath, Inc. All rights reserved.